Chronic Intermittent Hypobaric Hypoxia Pretreatment Ameliorates Ischemia-Induced Cognitive Dysfunction Through Activation of ERK1/2-CREB-BDNF Pathway in Anesthetized Mice
- 362 Downloads
Chronic intermittent hypobaric hypoxia (CIHH) has protective effects on heart and brain against ischemia injury through mobilizing endogenous adaptive mechanisms. However, whether CIHH prevents against cognitive impairment was not elucidated. The present study aimed to investigate the effect and mechanism of CIHH treatment on ischemia/reperfusion (IR)-induced cognitive dysfunction. Mice were randomly divided into 8 groups: Control, Sham, CIHH (simulating 5000 m high-altitude for 28 days, 6 h per day), IR (three 16-min occlusions of bilateral common carotid arteries interrupted by two 10-min intervals), CIHH + IR, PD98059 (inhibitor of MEK1/2) + CIHH + IR, PD98059 + Sham and PD98059 + IR group. Morris water maze and step-down passive avoidance tests were performed to evaluate the capability of learning and memory 1 month after ischemia. Thionine dyeing was to examine histological manifestations of pyramidal neurons in hippocampus CA1 region. Western blotting assay was for measurement of the protein expressions in ERK1/2-CREB-BDNF signaling pathway. There were a shorter escape latency and a longer percentage of time retaining in the target quadrant in Morris water maze test, fewer times of errors in the step-down avoidance test and a higher neuronal density of the hippocampal CA1 subfield in CIHH + IR group than in IR group. CIHH upregulated the expressions of BDNF, phosphorylated CREB, ERK1/2 and TrkB with or without ischemia. The protective effects of CIHH were abolished by PD98059 administration 15 min before ischemia. CIHH ameliorated ischemia-induced cognitive dysfunction through activation of ERK1/2-CREB-BDNF signaling pathway.
KeywordsChronic intermittent hypobaric hypoxia Cognitive dysfunction Ischemia/reperfusion Brain-derived neurotrophic factor Extracellular signal-regulated kinases Mouse
This work was supported by Natural Science Foundation of Hebei Province, China (C2014206363) and Hebei Province Students innovative and entrepreneurial project (201510089016).
Designed experiment and wrote manuscript: YL. Performed experiment: JW, ZL, XW. Analyzed data: HuijuanMa. Wrote manuscript: SZ. Reviewed and approved the final version of the manuscript: SW, YZ.
Compliance with Ethical Standards
Conflict of interest
Authors have no conflict of interest in this study.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- 7.Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M (2011) Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35:1836–1840. doi: 10.1016/j.pnpbp.2011.09.004 CrossRefPubMedGoogle Scholar
- 8.Asevedo E, Gadelha A, Noto C, Mansur RB, Zugman A, Belangero SI, Berberian AA, Scarpato BS, Leclerc E, Teixeira AL, Gama CS, Bressan RA, Brietzke E (2013) Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. J Psychiatr Res 47:1376–1382. doi: 10.1016/j.jpsychires.2013.05.032 CrossRefPubMedGoogle Scholar
- 9.Guo X, Chen ZH, Wang HL, Liu ZC, Wang XP, Zhou BH, Yang C, Zhang XP, Xiao L, Shu C, Chen JX, Wang GH (2015) WSKY, a traditional Chinese decoction, rescues cognitive impairment associated with NMDA receptor antagonism by enhancing BDNF/ERK/CREB signaling. Mol Med Rep 11:2927–2934. doi: 10.3892/mmr.2014.3086 PubMedGoogle Scholar
- 12.Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Graos MM, Carvalho RF, Carvalho AP, Duarte CB (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12:1329–1343. doi: 10.1038/sj.cdd.4401662 CrossRefPubMedGoogle Scholar
- 19.Zhu XH, Yan HC, Zhang J, Qu HD, Qiu XS, Chen L, Li SJ, Cao X, Bean JC, Chen LH, Qin XH, Liu JH, Bai XC, Mei L, Gao TM (2010) Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci 30:12653–12663. doi: 10.1523/jneurosci.6414-09.2010 CrossRefPubMedGoogle Scholar
- 20.Gong SJ, Chen LY, Zhang M, Gong JX, Ma YX, Zhang JM, Wang YJ, Hu YY, Sun XC, Li WB, Zhang Y (2012) Intermittent hypobaric hypoxia preconditioning induced brain ischemic tolerance by up-regulating glial glutamate transporter-1 in rats. Neurochem Res 37:527–537. doi: 10.1007/s11064-011-0639-3 CrossRefPubMedGoogle Scholar
- 21.Rybnikova E, Mironova V, Pivina S, Tulkova E, Ordyan N, Nalivaeva N, Turner A, Samoilov M (2007) Involvement of the hypothalamic–pituitary–adrenal axis in the antidepressant-like effects of mild hypoxic preconditioning in rats. Psychoneuroendocrinology 32:813–823. doi: 10.1016/j.psyneuen.2007.05.010 CrossRefPubMedGoogle Scholar
- 29.Udayabanu M, Kumaran D, Nair RU, Srinivas P, Bhagat N, Aneja R, Katyal A (2008) Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia. Brain Res 1230:138–149. doi: 10.1016/j.brainres.2008.06.081 CrossRefPubMedGoogle Scholar
- 32.Lee KY, Jeong EJ, Huh J, Cho N, Kim TB, Jeon BJ, Kim SH, Kim HP, Sung SH (2012) Cognition-enhancing and neuroprotective activities of the standardized extract of Betula platyphylla bark and its major diarylheptanoids. Phytomedicine 19:1315–1320. doi: 10.1016/j.phymed.2012.09.012 CrossRefPubMedGoogle Scholar
- 34.Mou L, Heldt SA, Ressler KJ (2011) Rapid brain-derived neurotrophic factor-dependent sequestration of amygdala and hippocampal GABA(A) receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 176:72–85. doi: 10.1016/j.neuroscience.2010.12.041 CrossRefPubMedGoogle Scholar
- 39.Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med 15:331–337. doi: 10.1038/nm.1912 CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Wang J, Ming H, Chen R, Ju JM, Peng WD, Zhang GX, Liu CF (2015) CIH-induced neurocognitive impairments are associated with hippocampal Ca(2+) overload, apoptosis, and dephosphorylation of ERK1/2 and CREB that are mediated by overactivation of NMDARs. Brain Res 1625:64–72. doi: 10.1016/j.brainres.2015.08.012 CrossRefPubMedGoogle Scholar
- 49.Jeon SJ, Rhee SY, Seo JE, Bak HR, Lee SH, Ryu JH, Cheong JH, Shin CY, Kim GH, Lee YS, Ko KH (2011) Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. Neurosci Res 69:214–222. doi: 10.1016/j.neures.2010.11.008 CrossRefPubMedGoogle Scholar
- 52.Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A (2005) Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 24:165–177. doi: 10.1038/sj.onc.1208000 CrossRefPubMedGoogle Scholar